Rafferty Asset Management »

Immix Biopharma shares owned by Rafferty Asset Management

Quarter-by-quarter ownership of Immix Biopharma (IMMX) shares owned by Rafferty Asset Management from 13F filings

Historical chart of Rafferty Asset Management investment in Immix Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Immix Biopharma held by Rafferty Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immix Biopharma by Rafferty Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $603k 59k 10.31

More positions owned by Rafferty Asset Management

Micron Technology (MU)
NVIDIA Corporation (NVDA)
Advanced Micro Devices (AMD)
Broadcom (AVGO)
Intel Corporation (INTC)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Applied Materials (AMAT)
Kla Corp Com New (KLAC)
Marvell Technology (MRVL)
Lam Research Corp Com New (LRCX)
Ishares Msci Sth Kor Etf (EWY)
Ishares Tr Russell 2000 Etf (IWM)
Apple (AAPL)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Texas Instruments Incorporated (TXN)

View all positions for Rafferty Asset Management

Top funds holding Immix Biopharma

Jupiter Topco
Henderson Group
Saturn V Capital Management
Eventide Asset Management
BlackRock
Deep Track Capital
Vanguard Capital Management
Opaleye Management
Millennium Management
UBS Group
Marshall Wace
Wellington Management Company
Dr. Jeffrey R. Jay, M.D.
Geode Capital Management
Velan Capital Investment Management

View all funds holding Immix Biopharma